# A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.

> **NCT00842400** · PHASE1 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 20 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Metformin, VI-0521, Sitagliptan, Probenecid

## Key facts

- **NCT ID:** NCT00842400
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-03
- **Final completion:** 2009-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2010-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842400, "A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00842400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*